Abiogen Pharma SpA

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly Will Try Camurus’s FluidCrystal D

Spanish biosimilars developer mAbxience has struck a deal with Italy’s Abiogen Pharma giving it Italian rights to an undisclosed biosimilar candidate. The firms said that mAbxience – which is majority

By acquiring the small New York-based company, Averitas Pharma , the family-owned European-based specialty company, Grunenthal GMBH , is aiming to use Averitas's experience in a specialty pharmacy a

The progression of investigational products through a series of increasingly sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for commer